Total Payments
$355.14
2024 Payments
$49.37
Companies
10
Transactions
10
Medicare Patients
2,193
Medicare Billing
$326,456
Payment Breakdown by Category
Food & Beverage$184.49 (51.9%)
Education$170.65 (48.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $184.49 | 4 | 51.9% |
| Education | $170.65 | 6 | 48.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $121.47 | 1 | $0 (2023) |
| Lilly USA, LLC | $101.43 | 1 | $0 (2023) |
| ABBVIE INC. | $32.35 | 1 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $18.17 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $16.57 | 1 | $0 (2023) |
| PFIZER INC. | $13.34 | 1 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $12.50 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| Ipsen Biopharmaceuticals, Inc | $10.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.37 | 2 | ABBVIE INC. ($32.35) |
| 2023 | $239.47 | 3 | Intuitive Surgical, Inc. ($121.47) |
| 2022 | $31.51 | 2 | Adaptive Biotechnologies Corporation ($18.17) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2018 | $12.50 | 1 | Pharmacyclics LLC, An AbbVie Company ($12.50) |
| 2017 | $10.37 | 1 | Ipsen Biopharmaceuticals, Inc ($10.37) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 07/04/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: SURGERY | ||||||
| 06/12/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $16.57 | General |
| Category: Oncology | ||||||
| 02/09/2023 | Lilly USA, LLC | RETEVMO (Drug) | Education | In-kind items and services | $101.43 | General |
| Category: Oncology | ||||||
| 08/31/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 04/28/2022 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/02/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Oncology | ||||||
| 05/30/2017 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Education | In-kind items and services | $10.37 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 598 | 1,030 | $332,064 | $93,314 |
| 2022 | 6 | 531 | 910 | $284,868 | $81,089 |
| 2021 | 6 | 531 | 884 | $281,051 | $80,556 |
| 2020 | 6 | 533 | 947 | $295,505 | $71,498 |
Total Patients
2,193
Total Services
3,771
Medicare Billing
$326,456
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 140 | 409 | $153,375 | $44,023 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 394 | $109,926 | $28,232 | 25.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 78 | $14,274 | $7,243 | 50.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 44 | $23,232 | $5,837 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $17,721 | $4,639 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 72 | $13,536 | $3,339 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 127 | 364 | $129,948 | $38,817 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 368 | $97,520 | $24,585 | 25.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 44 | $21,707 | $6,798 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $18,396 | $4,825 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 49 | $8,526 | $3,948 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 49 | $8,771 | $2,115 | 24.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 112 | 336 | $119,952 | $36,059 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 227 | 332 | $87,980 | $22,957 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 53 | 53 | $26,606 | $7,987 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 53 | 53 | $27,083 | $6,941 | 25.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 52 | $9,048 | $4,179 | 46.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 58 | $10,382 | $2,433 | 23.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 107 | 321 | $113,677 | $26,311 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 234 | 412 | $108,516 | $23,287 | 21.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 52 | 53 | $26,461 | $8,653 | 32.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 56 | 56 | $28,361 | $7,327 | 25.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 49 | $8,506 | $4,118 | 48.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 56 | $9,984 | $1,802 | 18.0% |
About Priya Jain
Priya Jain is a Internal Medicine healthcare provider based in Kettering, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912093360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Priya Jain has received a total of $355.14 in payments from pharmaceutical and medical device companies, with $49.37 received in 2024. These payments were reported across 10 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($184.49).
As a Medicare-enrolled provider, Jain has provided services to 2,193 Medicare beneficiaries, totaling 3,771 services with total Medicare billing of $326,456. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Kettering, OH
- Active Since 10/05/2006
- Last Updated 08/27/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912093360
Products in Payments
- Da Vinci Surgical System (Device) $121.47
- RETEVMO (Drug) $101.43
- IMBRUVICA (Drug) $32.35
- clonoSEQ (Device) $18.17
- LIBTAYO (Biological) $17.02
- OPDIVO (Biological) $16.57
- INLYTA (Drug) $13.34
- Imbruvica (Drug) $12.50
- Onivyde (Drug) $10.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kettering
Saleem Ahmad, M.d, M.D
Internal Medicine — Payments: $39,651
Internal Medicine $39,651
Malek Safa, M.d, M.D
Internal Medicine — Payments: $16,090
Internal Medicine $16,090
Dr. Rami Alashram
Internal Medicine — Payments: $6,176
Internal Medicine $6,176
Dr. Carlos Ventura, M.d, M.D
Internal Medicine — Payments: $6,043
Internal Medicine $6,043
Dr. Archana Kodali, M.d, M.D
Internal Medicine — Payments: $5,326
Internal Medicine $5,326
Mrs. Kelly Miller, Md, Phd, MD, PHD
Internal Medicine — Payments: $3,766
Internal Medicine $3,766